Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $56.00 Price Target at Oppenheimer
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its target price reduced by Oppenheimer from $60.00 to $56.00 in a research report released on Wednesday,Benzinga reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. CRBP has been the topic of several other reports. Jefferies Financial Group lowered their price target on shares of […]
More Stories
Freight Train Derails in Connecticut, Sending Cars Carrying Liquid Propane Into River
By The Associated Press MANSFIELD, Conn.—A freight train derailed Thursday in Connecticut, sending cars carrying flammable liquid propane into the...
Trump Calls for New Nuclear Arms Control Treaty as New START Expires
By Ryan Morgan U.S. President Donald Trump called for a new nuclear arms control treaty on Feb. 5, as the...
Bitcoin Slips Below $70,000 as Crypto Sell-Off Continues
By Andrew Moran Winter has arrived in the cryptocurrency market, as bitcoin has fallen below $70,000 for the first time...
Trump Launches TrumpRx Website for Discount Pharmaceutical Drugs
By Travis Gillmore President Donald Trump addressed the nation on Thursday night to announce the launch of TrumpRx.com featuring medicine...
Netflix CEO Faces Criticism From Lawmakers on Warner Merger
By Kevin Stocklin While Congress may have little say in whether Netflix’s proposed merger with Warner Bros. goes through, senators...
Georgia’s Fulton County Sues for Return of 2020 Election Documents Seized by FBI
By Matthew Vadum Fulton County, Georgia, is suing the federal government for the return of 2020 election documents that the...